Ellington Financial, Inc.

  • Market Cap: Small Cap
  • Industry: Realty
  • ISIN: US28852N1090
USD
13.72
0.09 (0.66%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Ellington Financial, Inc. stock-summary
stock-summary
Ellington Financial, Inc.
Realty
Ellington Financial Inc, formerly Ellington Financial LLC is a specialty finance company that acquires and manages mortgage-related and other financial assets. The Company invests in a range of financial assets, including residential and commercial mortgage-backed securities, residential and commercial mortgage loans, consumer loans and asset-backed securities backed by consumer loans, collateralized loan obligations, non-mortgage and mortgage-related derivatives, equity investments in loan origination companies, and other strategic investments, collectively referred to as non-Agency RMBS; RMBS for which the principal and interest payments are guaranteed by the United States government agency or the United States government-sponsored entity (Agency RMBS); commercial mortgage-backed securities (CMBS) commercial mortgage loans; residential mortgage loans; collateralized loan obligations; corporate debt and equity, including distressed debt and equity, and mortgage-related derivatives.
Company Coordinates stock-summary
Company Details
53 Forest Ave , OLD GREENWICH CT : 06870-1526
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 42 Schemes (32.95%)

Foreign Institutions

Held by 59 Foreign Institutions (4.65%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Thomas Robards
Independent Chairman of the Board
Mr. Laurence Penn
President, Chief Executive Officer, Director
Ms. Lisa Mumford
Director
Mr. Edward Resendez
Independent Director
Dr. Ronald Simon
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
133 Million
(Quarterly Results - Jun 2025)
Net Profit:
51 Million
stock-summary
Industry

Realty

stock-summary
Market cap

USD 1,369 Million (Small Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

3.44%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

8.44%

stock-summary
Price to Book

0.82